BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer

NCT00004122 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

BIOLOGICAL: BCG vaccine
BIOLOGICAL: recombinant interferon alfa

Sponsor

Roswell Park Cancer Institute

Collaborators

[object Object]